Malaria Burden and Artemisinin Resistance in the Mobile and Migrant Population on the Thai–Myanmar Border, 1999–2011: An Observational Study
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Shoklo Malaria Research Unit has been working on the Thai-Myanmar border for 25 y providing early diagnosis and treatment (EDT) of malaria. Transmission of Plasmodium falciparum has declined, but resistance to artesunate has emerged. We expanded malaria activities through EDT and evaluated the impact over a 12-y period. METHODS AND FINDINGS: Between 1 October 1999 and 30 September 2011, the Shoklo Malaria Research Unit increased the number of cross-border (Myanmar side) health facilities from two to 11 and recorded the number of malaria consultations. Changes in malaria incidence were estimated from a cohort of pregnant women, and prevalence from cross-sectional surveys. In vivo and in vitro antimalarial drug efficacy were monitored. Over this period, the number of malaria cases detected increased initially, but then declined rapidly. In children under 5 y, the percentage of consultations due to malaria declined from 78% (95% CI 76-80) (1,048/1,344 consultations) to 7% (95% CI 6.2-7.1) (767/11,542 consultations), p<0.001. The ratio of P. falciparum/P. vivax declined from 1.4 (95% CI 1.3-1.4) to 0.7 (95% CI 0.7-0.8). The case fatality rate was low (39/75,126; 0.05% [95% CI 0.04-0.07]). The incidence of malaria declined from 1.1 to 0.1 episodes per pregnant women-year. The cumulative proportion of P. falciparum decreased significantly from 24.3% (95% CI 21.0-28.0) (143/588 pregnant women) to 3.4% (95% CI 2.8-4.3) (76/2,207 pregnant women), p<0.001. The in vivo efficacy of mefloquine-artesunate declined steadily, with a sharp drop in 2011 (day-42 PCR-adjusted cure rate 42% [95% CI 20-62]). The proportion of patients still slide positive for malaria at day 3 rose from 0% in 2000 to reach 28% (95% CI 13-45) (8/29 patients) in 2011. CONCLUSIONS: Despite the emergence of resistance to artesunate in P. falciparum, the strategy of EDT with artemisinin-based combination treatments has been associated with a reduction in malaria in the migrant population living on the Thai-Myanmar border. Although limited by its observational nature, this study provides useful data on malaria burden in a strategically crucial geographical area. Alternative fixed combination treatments are needed urgently to replace the failing first-line regimen of mefloquine and artesunate. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The early detection and prompt treatment approach with combination therapy artesunate/mefloquine for P. falciparum and chloroquine for non-falciparum (principally P. vivax) infections, introduced in 1995, has been very effective and consistent with previous publications on malaria control in the Thailand-Myanmar border camps and for migrant populations (Landier et al., 2016; Carrara et al., 2013;”
From Mother, child and adolescent health outcomes in two long-term refugee camp settings at the Thai-Myanmar border 2000–2018: a retrospective analysis (2024) · cites this paper as Carrara et al., 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The dramatic decline in malaria burden observed in the camps paralleled with the decreasing malaria incidence in the migrant population on the Thai–Myanmar border (Carrara et al., 2013), as did the increasing contribution of P. vivax to overall malaria morbidity”
From Integrated primary health care services in two protracted refugee camp settings at the Thai–Myanmar border 2000–2018: trends on mortality and incidence of infectious diseases (2022) · cites this paper as Carrara et al., 2013
In the citing paper
“As far as the authors are aware, this is the largest cohort demonstrating a significant association with low BMI and malaria among pregnant women (56) and, therefore, the history of malaria control efforts along the border over the present study period bears mentioning.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424 · cited 2×
“falciparum isolates that exhibit resistance to artesunate [3].”
BackgroundSelf-citationArtesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67176-0 · Cited by 1,050
Dondorp, A. M., Fanello, C. I., Hendriksen, I. C., Gomes, E., Seni, A., Chhaganlal, K. D., Bojang, K., Olaosebikan, R., Anunobi, N., Maitland, K., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61924-1 · Cited by 1,022
Self-citationThe global distribution and population at risk of malaria: past, present, and future
Hay, S. I., Guerra, C. A., Tatem, A. J., Noor, A. M., & Snow, R. W. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01043-6 · Cited by 1,001 · cited 1×
“In other continents, malaria has receded too, particularly in Southeast Asia, although the precise number of cases in some countries of the subcontinent may have been grossly underestimated [2].”
BackgroundEmergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
Phyo, A. P., Nkhoma, S., Stepniewska, K., Ashley, E. A., Nair, S., McGready, R., ler Moo, C., Al-Saai, S., Dondorp, A. M., Lwin, K. M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60484-x · Cited by 924 · cited 2×
“falciparum resistance to artesunate [4].”
BackgroundSelf-citationDeterminants of relapse periodicity in Plasmodium vivax malaria
White, N. J. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-297 · Cited by 679
Self-citationNosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S., & White, N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02505-8 · Cited by 500 · cited 1×
“Between 1994 and 1999 we observed the impact of early detection and treatment (EDT) with ACT in populations of refugees living on the Thai–Myanmar border [9].”
BackgroundSelf-citationA Major Genome Region Underlying Artemisinin Resistance in Malaria
Cheeseman, I. H., Miller, B. A., Nair, S., Nkhoma, S., Tan, A., Tan, J. C., Al Saai, S., Phyo, A. P., Moo, C. L., Lwin, K. M., et al. (2012) · Science · doi:10.1126/science.1215966 · Cited by 381
Self-citationBarnes, K. I., Durrheim, D. N., Little, F., Jackson, A., Mehta, U., Allen, E., Dlamini, S. S., Tsoka, J., Bredenkamp, B., Mthembu, D. J., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020330 · Cited by 285 · cited 4×
“This approach used by SMRU as well as other health providers in the area had proven effectiveness first in the refugee camps on the Thai border in the 1990s , then in Thai villages of Tak province and elsewhere in the region [ 14 ] , and even in low transmission areas of Africa [ 15 ] .”
MethodInfluentialSelf-citationDelaying antimalarial drug resistance with combination chemotherapy.
White, N. J. (1999) · Parassitologia · Cited by 260
Self-citation
Cited by
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205
Self-citationAntimalarial Drug Resistance: A Threat to Malaria Elimination
Menard, D., & Dondorp, A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025619 · Cited by 499
“2016) and with artesunate–mefloquine on the Thai–Myanmar border (Carrara et al. 2013).”
BackgroundInfluentialWorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group (2015) · BMC Medicine · doi:10.1186/s12916-015-0456-7 · Cited by 464
Tun, K. M., Imwong, M., Lwin, K. M., Win, A. A., Hlaing, T. M., Hlaing, T., Lin, K., Kyaw, M. P., Plewes, K., Faiz, M. A., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70032-0 · Cited by 414
Self-citationArtemisinin Action and Resistance in Plasmodium falciparum
Tilley, L., Straimer, J., Gnädig, N. F., Ralph, S. A., & Fidock, D. A. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.05.010 · Cited by 359
“Thus it is of acute concern that resistance to the artemisinin derivatives (ARTs, see Glossary), the first-line drug class used to treat malaria, emerged several years ago, and is now evident in six countries in South East Asia.”
Malaria incidence in Myanmar 2005–2014: steady but fragile progress towards elimination
Mu, T. T., Sein, A. A., Kyi, T. T., Min, M., Aung, N. M., Anstey, N. M., Kyaw, M. P., Soe, C., Kyi, M. M., & Hanson, J. (2016) · Malaria Journal · doi:10.1186/s12936-016-1567-0 · Cited by 333
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread
Woodrow, C. J., & White, N. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw037 · Cited by 251
“…evidence for steadily increasing artemisinin resistance over the past decade (Phyo et al. 2012), culminating in the loss of artesunate-mefloquine efficacy in a manner similar to that observed approximately five years earlier in western Cambodia (Na-Bangchang et al. 2010; Carrara et al. 2013).”
ResultSelf-citationPhyo, A. P., Ashley, E. A., Anderson, T. J. C., Bozdech, Z., Carrara, V. I., Sriprawat, K., Nair, S., White, M. M., Dziekan, J., Ling, C., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw388 · Cited by 244
Self-citationImwong, M., Nguyen, T. N., Tripura, R., Peto, T. J., Lee, S. J., Lwin, K. M., Suangkanarat, P., Jeeyapant, A., Vihokhern, B., Wongsaen, K., et al. (2015) · Malaria Journal · doi:10.1186/s12936-015-0906-x · Cited by 214
“vivax now predominates [10].”
Self-citationPoespoprodjo, J. R., Douglas, N. M., Ansong, D., Kho, S., & Anstey, N. M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01249-7 · Cited by 204
Phyo, A. P., Jittamala, P., Nosten, F. H., Pukrittayakamee, S., Imwong, M., White, N. J., Duparc, S., Macintyre, F., Baker, M., & Möhrle, J. J. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00320-5 · Cited by 185
Self-citationCross-Border Malaria: A Major Obstacle for Malaria Elimination
Wangdi, K., Gatton, M. L., Kelly, G. C., & Clements, A. C. (2015) · Advances in Parasitology · doi:10.1016/bs.apar.2015.04.002 · Cited by 168
“For instance, economic stagnation in Myanmar and rapid economic development in Thailand has stimulated migration from Myanmar to Thailand (Carrara et al., 2013; Delacollette et al., 2009; Huguet and Punpuing, 2005; Khamsiriwatchara et al., 2011; Wangroongsarb et al., 2012), while temporary…”
BackgroundInfluentialThe role of early detection and treatment in malaria elimination
Landier, J., Parker, D. M., Thu, A. M., Carrara, V. I., Lwin, K. M., Bonnington, C. A., Pukrittayakamee, S., Delmas, G., & Nosten, F. H. (2016) · Malaria Journal · doi:10.1186/s12936-016-1399-y · Cited by 170
“On the Thai-Myanmar border, 15 years of EDT with ACT in clinics serving migrant and displaced populations drastically reduced the incidence of falciparum malaria [45, 46].”
MethodSelf-citationvon Seidlein, L., Peto, T. J., Landier, J., Nguyen, T.-N., Tripura, R., Phommasone, K., Pongvongsa, T., Lwin, K. M., Keereecharoen, L., Kajeechiwa, L., et al. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002745 · Cited by 158
Self-citationArtemisinin resistance – modelling the potential human and economic costs
Lubell, Y., Dondorp, A. M., Guerin, P. J., Drake, T., Meek, S. R., Ashley, E. A., Day, N., White, N. J., & White, L. J. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-452 · Cited by 173
“Early warning signs in the form of slowing parasite clearance times in western Cambodia were detected in 2007 and soon after along the Thai-Burmese border [5,10,11].”
BackgroundResultSelf-citationMalaria ecology along the Thailand-Myanmar border.
Parker, D. M., Carrara, V. I., Pukrittayakamee, S., McGready, R., & Nosten, F. H. (2015) · Malaria Journal · doi:10.1186/s12936-015-0921-y · Cited by 142
“2) [76, 77], and health care providers tend to cluster in urban centres.”
BackgroundSelf-citationManagement of relapsing Plasmodium vivax malaria
Chu, C. S., & White, N. J. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1220304 · Cited by 130
Self-citationNumerical Distributions of Parasite Densities During Asymptomatic Malaria
Imwong, M., Stepniewska, K., Tripura, R., Peto, T. J., Lwin, K. M., Vihokhern, B., Wongsaen, K., von Seidlein, L., Dhorda, M., Snounou, G., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv596 · Cited by 141
Self-citationTalundzic, E., Okoth, S. A., Congpuong, K., Pluciński, M. M., Morton, L. C., Goldman, I. F., Kachur, S. P., Wongsrichanalai, C., Satimai, W., Barnwell, J. W., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004789 · Cited by 119
Taylor, A. R., Schaffner, S. F., Cerqueira, G. C., Nkhoma, S. C., Anderson, T. J. C., Sriprawat, K., Pyae Phyo, A., Nosten, F., Neafsey, D. E., & Buckee, C. O. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1007065 · Cited by 134
“Briefly, 1173 filter paper blood spots were collected between 2001 and 2010 from hyper-parasitaemic patients (> 4% infected red blood cells) with uncomplicated P. falciparum malaria presenting at four SMRU clinics on the Thai-Myanmar border (Fig 1).”
BackgroundInfluentialSelf-citationAntimalarial Activity of KAF156 in Falciparum and Vivax Malaria
White, N. J., Duong, T. T., Uthaisin, C., Nosten, F. H., Phyo, A. P., Hanboonkunupakarn, B., Pukrittayakamee, S., Jittamala, P., Chuthasmit, K., Cheung, M. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602250 · Cited by 114
Self-citationPopulation Parameters Underlying an Ongoing Soft Sweep in Southeast Asian Malaria Parasites
Anderson, T. J. C., Nair, S., McDew‐White, M., Cheeseman, I. H., Nkhoma, S. C., Bilgic, F., McGready, R. M., Ashley, E. A., Phyo, A. P., White, N. J., et al. (2016) · Molecular Biology and Evolution · doi:10.1093/molbev/msw228 · Cited by 114
“(c) In 2014, we supplemented the numbers of samples by collecting blood spots from uncomplicated malaria patients admitted for treatment at SMRU clinics, because P. falciparum cases are declining rapidly in this region (Carrara et al. 2013; Nkhoma et al. 2013).”
BackgroundMethodSelf-citationPlasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook
Siddiqui, F. A., Liang, X., & Cui, L. (2021) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2021.05.007 · Cited by 126
Characterization of G6PD Genotypes and Phenotypes on the Northwestern Thailand-Myanmar Border
Bancone, G., Chu, C. S., Somsakchaicharoen, R., Chowwiwat, N., Parker, D. M., Charunwatthana, P., White, N. J., & Nosten, F. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116063 · Cited by 99
“The population living in border villages is estimated to be over 250,000 [15], consisting mainly of the Karen and Burman ethnicities.”
BackgroundSelf-citationMalaria Elimination and Eradication
Shretta, R., Liu, J. X., Cotter, C., Cohen, J. M., Dolenz, C., Makomva, K., Newby, G., Ménard, D., Phillips, A. A., Tatarsky, A., et al. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0524-0_ch12 · Cited by 123
Landier, J., Kajeechiwa, L., Thwin, M. M., Parker, D. M., Chaumeau, V., Wiladphaingern, J., Imwong, M., Miotto, O., Patumrat, K., Duanguppama, J., et al. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.12240.1 · Cited by 87
“Population during MDA period and MDA coverage: n (%) Present at least once during the 3 MDA months 386 (100) 662 (100) 367 (100) 977 (100) Present continuously during 3 MDA months 280 (73) 488 (74) 283 (77) 618 (63) Taking 0 round of MDA 26 (7) 175 (26) 28 (8) 297 (30) Taking 1 round of MDA 60 (16) 180 (27) 64 (17) 22…”
Self-citationSmith, C. P., & Whittaker, M. A. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-307 · Cited by 86
Sriwichai, P., Karl, S., Samung, Y., Kiattibutr, K., Sirichaisinthop, J., Müeller, I., Cui, L., & Sattabongkot, J. (2017) · Malaria Journal · doi:10.1186/s12936-017-1900-2 · Cited by 81
Chu, C. S., Phyo, A. P., Turner, C. L., Win, H. H., Poe, N. P., Yotyingaphiram, W., Thinraow, S., Wilairisak, P., Raksapraidee, R., Carrara, V. I., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy735 · Cited by 87
“The patient population comprised migrant workers and displaced persons of Burman and Karen ethnicities [17].”
BackgroundSelf-citationBancone, G., Chowwiwat, N., Somsakchaicharoen, R., Poodpanya, L., Moo, P. K., Gornsawun, G., Kajeechiwa, L., Thwin, M. M., Rakthinthong, S., Nosten, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151898 · Cited by 77
Self-citationPatel, J. C., Lucchi, N. W., Srivastava, P., Lin, J. T., Sugaram, R., Aruncharus, S., Bharti, P. K., Shukla, M. M., Congpuong, K., Satimai, W., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu252 · Cited by 83
Kenangalem, E., Poespoprodjo, J. R., Douglas, N. M., Burdam, F. H., Gdeumana, K., Chalfein, F., Prayoga, Thio, F., Devine, A., Marfurt, J., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002815 · Cited by 77
“The replacement of failing treatment regimens with highly efficacious schizontocidal treatment has potential to reduce malaria-related morbidity and mortality and decrease the risk of recurrent parasitaemia and ongoing transmission [30].”
BackgroundGuyant, P., Corbel, V., Guérin, P. J., Lautissier, A., Nosten, F., Boyer, S., Coosemans, M., Dondorp, A. M., Sinou, V., Yeung, S., et al. (2015) · Malaria Journal · doi:10.1186/s12936-015-0802-4 · Cited by 70
“Due to their mobility patterns, the remoteness of their location or the illegal aspects of their activity, these mobile and migrant populations, are often hard to reach with current malaria tools and interventions [29–31].”
BackgroundSelf-citationGhinai, I., Cook, J. A., Hla, T. T. W., Htet, H. M. T., Hall, T., Lubis, I. N. D., Ghinai, R., Hesketh, T. M., Naung, Y., Lwin, M. M., et al. (2017) · Malaria Journal · doi:10.1186/s12936-016-1651-5 · Cited by 78
“Malaria distribution in Myanmar is heterogeneous; forests are a major environmental factor driving patterns of disease [11, 12] and international and internal migration are also risk factors [13, 14].”
Feng, J., Liu, J., Feng, X., Zhang, L., Xiao, H.-H., & Xia, Z. (2016) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0888 · Cited by 70
“Another factor is the great difficulty of tracking cases in the mobile population at the border.(32) Currently in China, malaria case follows the principle of localized management.”
BackgroundChu, C. S., Phyo, A. P., Lwin, K. M., Win, H. H., San, T., Aung, A. A., Raksapraidee, R., Carrara, V. I., Bancone, G., Watson, J., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy319 · Cited by 64
“Malaria transmission in this tropical mountainous region is low and seasonal [6, 7].”
BackgroundSelf-citationKrishna, S., & Kremsner, P. G. (2013) · Trends in Parasitology · doi:10.1016/j.pt.2013.04.001 · Cited by 64
Challenges and prospects for dengue and malaria control in Thailand, Southeast Asia
Corbel, V., Nosten, F. H., Thanispong, K., Luxemburger, C., Kongmee, M., & Chareonviriyaphap, T. (2013) · Trends in Parasitology · doi:10.1016/j.pt.2013.09.007 · Cited by 59
Self-citationAn outbreak of artemisinin resistant falciparum malaria in Eastern Thailand
Imwong, M., Jindakhad, T., Kunasol, C., Sutawong, K., Vejakama, P., & Dondorp, A. M. (2015) · Scientific Reports · doi:10.1038/srep17412 · Cited by 58
Wen, S., Harvard, K. E., Gueye, C. S., Canavati, S. E., Chancellor, A., Ahmed, B., Leaburi, J., Lek, D., Namgay, R., Surya, A., et al. (2016) · Malaria Journal · doi:10.1186/s12936-016-1319-1 · Cited by 68
“Other identified populations at higher risk in the Asia Pacific region include laborers returning from malaria-endemic regions in other countries [29–32] or within the same country [23, 33] who travel to non-endemic regions, mobile ethnic groups [18, 22, 24, 31], rural indigenous communities [4, 22, 23], migrants [24,…”
BackgroundAnopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border
Ya-umphan, P., Cerqueira, D., Parker, D. M., Cottrell, G., Poinsignon, A., Remoue, F., Brengues, C., Chareonviriyaphap, T., Nosten, F., & Corbel, V. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw543 · Cited by 53
“Malaria transmission along the Thailand-Myanmar border is high because of extensive population movement across the border, especially mobile and forest workers, who make a substantial contribution to the regional malaria burden [2].”
InfluentialSelf-citationArtemisinin resistance is a clear and present danger
Dondorp, A. M., & Ringwald, P. (2013) · Trends in Parasitology · doi:10.1016/j.pt.2013.05.005 · Cited by 57
Aptamer Technology: Adjunct Therapy for Malaria
Kamarudin, N. A. A. N., Mohammed, N., & Mustaffa, K. M. F. (2017) · Biomedicines · doi:10.3390/biomedicines5010001 · Cited by 57
Tun, K. M., Jeeyapant, A., Imwong, M., Thein, M., Aung, S., Hlaing, T. M., Yuentrakul, P., Promnarate, C., Dhorda, M., Woodrow, C. J., et al. (2016) · Malaria Journal · doi:10.1186/s12936-016-1240-7 · Cited by 56
“Artemisinin resistance has steadily worsened along the Myanmar–Thailand border [17, 18] where the k13 C580Y mutation now predominates, and is present in central and southern Myanmar where independent mutations have emerged [2, 3, 19].”
BackgroundSelf-citationLawpoolsri, S., Sattabongkot, J., Sirichaisinthop, J., Cui, L., Kiattibutr, K., Rachaphaew, N., Suk-uam, K., Khamsiriwatchara, A., & Kaewkungwal, J. (2019) · Malaria Journal · doi:10.1186/s12936-019-2763-5 · Cited by 67
Leitgeb, A. M., Charunwatthana, P., Rueangveerayut, R., Uthaisin, C., Silamut, K., Chotivanich, K., Sila, P., Moll, K., Lee, S. J., Lindgren, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188754 · Cited by 61
“The population has very little naturally acquired immunity against malaria [34].”
BackgroundHealth equity and migrants in the Greater Mekong Subregion
McMichael, C., & Healy, J. (2017) · Global Health Action · doi:10.1080/16549716.2017.1271594 · Cited by 53
Molecular Farming in Artemisia annua, a Promising Approach to Improve Anti-malarial Drug Production
Pulice, G., Pelaz, S., & Matías-Hernández, L. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00329 · Cited by 53
“…was provoked by data indicating that AN resistance had already emerged in small areas of Cambodia, Thailand, Vietnam, and Myanmar (Denis et al., 2006; Noedl et al., 2008; Dondorp et al., 2009; Rogers et al., 2009; Carrara et al., 2013; Leang et al., 2013; Saunders et al., 2014; Tun et al., 2015).”
BackgroundMercado, C. E. G., Lawpoolsri, S., Sudathip, P., Kaewkungwal, J., Khamsiriwatchara, A., Ngum, W. P., Yimsamran, S., Lawawirojwong, S., Ho, K., Ekapirat, N., et al. (2019) · Malaria Journal · doi:10.1186/s12936-019-2871-2 · Cited by 60
Self-citationLiu, H., Xu, J.-W., Guo, X.-R., Havumaki, J., Lin, Y.-X., Yu, G.-C., & Zhou, D.-L. (2015) · Malaria Journal · doi:10.1186/s12936-015-0727-y · Cited by 56
“Factors such as economic development, urbanization, and largely unprecedented financial support have all contributed to the success in the fight against malaria [1].”
BackgroundChugh, M., Scheurer, C., Sax, S., Bilsland, E., van Schalkwyk, D. A., Wicht, K. J., Hofmann, N., Sharma, A. R., Bashyam, S., Singh, S. V., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03265-14 · Cited by 50
Zhou, G., Lo, E. Y. Y., Zhong, D., Wang, X., Wang, Y., Malla, S., Lee, M., Yang, Z., Cui, L., & Yan, G. (2016) · Malaria Journal · doi:10.1186/s12936-016-1512-2 · Cited by 55
Steinbrook, E., Min, M. C., Kajeechiwa, L., Wiladphaingern, J., Paw, M. K., Pimanpanarak, M. P. J., Hiranloetthanyakit, W., Min, A. M., Tun, N. W., Gilder, M. E., et al. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04276-5 · Cited by 46
“All services were free of charge [21] and attendance at ANCs was voluntary.”
BackgroundSelf-citationJacobson, J. O., Cueto, C., Smith, J. L., Hwang, J., Gosling, R. D., & Bennett, A. F. (2017) · Malaria Journal · doi:10.1186/s12936-017-1679-1 · Cited by 56
“Improving surveillance and response for high-risk populations is a high priority for malaria eliminating countries, and is especially urgent in southeast Asia where MMPs are thought to influence the spread of artemisinin resistance [46].”
BackgroundOrigin of Robustness in Generating Drug-Resistant Malaria Parasites
Kümpornsin, K., Modchang, C., Heinberg, A. R., Ekland, E. H., Jirawatcharadech, P., Chobson, P., Suwanakitti, N., Chaotheing, S., Wilairat, P., Deitsch, K., et al. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu140 · Cited by 50
“falciparum malaria patients at the Thailand– Cambodia and Thailand–Myanmar borders (Carrara et al. 2013).”
BackgroundMalaria Hyperendemicity and Risk for Artemisinin Resistance among Illegal Gold Miners, French Guiana
de Santi, V. P., Djossou, F., Barthes, N., Bogreau, H., Hyvert, G., Nguyen, C., Pelleau, S., Legrand, E., Musset, L., Nacher, M., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2205.151957 · Cited by 46
“Collaboration between countries of the Guiana Shield to control malaria among mobile populations is urgently needed (15).”
BackgroundKwansomboon, N., Chaumeau, V., Kittiphanakun, P., Cerqueira, D., Corbel, V., & Chareonviriyaphap, T. (2017) · Journal of Vector Ecology · doi:10.1111/jvec.12242 · Cited by 46
Elimination of Plasmodium falciparum in an area of multi-drug resistance
Lwin, K. M., Imwong, M., Suangkanarat, P., Jeeyapant, A., Vihokhern, B., Wongsaen, K., Snounou, G., Keereecharoen, L., White, N. J., & Nosten, F. (2015) · Malaria Journal · doi:10.1186/s12936-015-0838-5 · Cited by 43
Self-citationTalundzic, E., Chenet, S. M., Goldman, I. F., Patel, D. S., Nelson, J. A., Plucinski, M. M., Barnwell, J. W., & Udhayakumar, V. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136099 · Cited by 39
Banks, T., Kang, J., Watts, I., Tyrosvoutis, M. E. G., Min, A. M., Tun, N. W., Keereecharoen, L., Simmawong, W., Wanyatip, S., Hanboonkunupakarn, B., et al. (2016) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.7422 · Cited by 43
“Health care issues amongst migrant workers in Thailand and ASEAN are recognized [9] and in Tak Province with a large presence of registered and unregistered migrants, described for certain infectious diseases such as malaria [10] and tuberculosis [11] and pertaining to reproductive health care [12].”
BackgroundSelf-citationDefining the In Vivo Phenotype of Artemisinin-Resistant Falciparum Malaria: A Modelling Approach
White, L. J., Flegg, J. A., Phyo, A. P., Wiladpai-ngern, J. H., Bethell, D., Plowe, C. V., Anderson, T., Nkhoma, S. C., Nair, S., Tripura, R., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001823 · Cited by 43
“Failure rates between 20% and 40% at 42 days follow-up after treatment with DHA-piperaquine are now being observed in Western Cambodia [2], and high failure rates with artesunate-mefloquine are now being observed on the Thai-Myanmar border [3].”
BackgroundSelf-citationEthical aspects of malaria control and research
Jamrozik, E., de la Fuente-Núñez, V., Reis, A. A., Ringwald, P., & Selgelid, M. J. (2015) · Malaria Journal · doi:10.1186/s12936-015-1042-3 · Cited by 51
“The presence of impoverished, mobile and politically marginalized populations, including large numbers of refugees, are likely contributors to this phenomenon [24, 25].”
BackgroundObservational Studies on Evaluating the Safety and Adverse Effects of Traditional Chinese Medicine
Lai, J.-N., Tang, J.-L., & Wang, J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/697893 · Cited by 43
“Prospective and retrospective observational studies seem to have specific advantages when investigating the safety and adverse effects of TCM therapies, as well as possibly other alternative/complementary therapies.”
BackgroundSteinbrook, E., Min, M. C., Kajeechiwa, L., Wiladphaingern, J., Paw, M. K., Pimanpanarak, M., Hiranloetthanyakit, W., Min, A. M., Tun, N. W., Gilder, M. E., et al. (2020) · doi:10.1101/2020.11.13.20231464 · Cited by 43
Self-citationFeng, J., Zhou, D.-L., Lin, Y.-X., Xiao, H., Yan, H., & Xia, Z. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04843-14 · Cited by 42
Liu, H., Yang, H.-L., Tang, L.-H., Li, X.-L., Huang, F., Wang, J.-Z., Li, C.-F., Wang, H.-Y., Nie, R.-H., Guo, X.-R., et al. (2015) · Malaria Journal · doi:10.1186/s12936-015-0584-8 · Cited by 30
“falciparum, the strategy of EDT with ACT has reduced malaria in the migrant population living on the Thai-Myanmar border [48].”
BackgroundDevine, A., Parmiter, M., Chu, C. S., Bancone, G., Nosten, F. H., Price, R. N., Lubell, Y., & Yeung, S. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005602 · Cited by 39
“vivax transmission is seen in this area [3] with a frequent relapse pattern [25].”
BackgroundSelf-citationZhao, Y., Liu, Z., Soe, M. T., Wang, L., Soe, T. N., Wei, H., Than, A. A., Aung, P. L., Li, Y., Zhang, X., et al. (2019) · Genes · doi:10.3390/genes10090692 · Cited by 38
Tan, J. J. L., Capozzoli, M., Sato, M., Watthanaworawit, W., Ling, C. L., Mauduit, M., Malleret, B., Grüner, A.-C., Tan, R., Nosten, F. H., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003043 · Cited by 42
Self-citationEvolution from double to triple-antimalarial drug combinations
Shanks, G. D., Edstein, M. D., & Jacobus, D. P. (2014) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/tru199 · Cited by 37
Cheeseman, I. H., McDew‐White, M., Phyo, A. P., Sriprawat, K., Nosten, F. H., & Anderson, T. J. C. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msu397 · Cited by 42
Self-citationPutaporntip, C., Kuamsab, N., Kosuwin, R., Tantiwattanasub, W., Vejakama, P., Sueblinvong, T., Seethamchai, S., Jongwutiwes, S., & Hughes, A. L. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.10.027 · Cited by 36
“Besides independent occurrence of K13 propeller mutants among parasite populations in Thailand, our longitudinal analysis of Tak isolates was in line with previous reports on monitoring of clinical responses to ACT in the same endemic area [26–28], suggesting that propeller mutations exert important roles in treatment…”
ResultHashmi, A., Nyein, P. B., Pilaseng, K., Paw, M. K., Darakamon, M. C., Min, A. M., Charunwatthana, P., Nosten, F. H., McGready, R. M., & Carrara, V. I. (2019) · BMC Public Health · doi:10.1186/s12889-019-7825-7 · Cited by 37
Self-citationOliveira, M. D., Cenzi, G., Nunes, R. R., Andrighetti, C. R., Valadão, D. D. S., Reis, C. D., Simões, C. M. O., Nunes, R. D. C., Júnior, M., Taranto, A. G., et al. (2013) · Molecules · doi:10.3390/molecules181215276 · Cited by 32
Auburn, S., Serre, D., Pearson, R. D., Amato, R., Sriprawat, K., To, S., Handayuni, I., Suwanarusk, R., Russell, B., Drury, E., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw323 · Cited by 31
“This trend is consistent with the local discontinuation of MQ plus artesunate in 2012 following documentation of its declining efficacy in the region [40].”
ResultSelf-citationPollitt, L. C., Huijben, S., Sim, D. G., Salathé, R. M., Jones, M. J., & Read, A. F. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004019 · Cited by 35
Bannister-Tyrrell, M., Set, S., Sluydts, V., Gryseels, C., Mean, V., Kim, S., Sokny, M., Grietens, K. P., Coosemans, M., Ménard, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30193-3 · Cited by 30
Srimuang, K., Miotto, O., Lim, P., Fairhurst, R. M., Kwiatkowski, D. P., Woodrow, C. J., & Imwong, M. (2016) · Malaria Journal · doi:10.1186/s12936-016-1598-6 · Cited by 30
“High levels of pfmdr1 amplification are also present along the Thailand–Myanmar border, where they have persisted for over two decades [15, 37], although the efficacy of artesunate–mefloquine has dropped to unacceptable levels only within the last 5 years, following the emergence of artemisinin resistance [4, 7, 38].”
BackgroundMharakurwa, S., Sialumano, M., Liu, K., Scott, A. L., & Thuma, P. E. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-453 · Cited by 29
“Plasmodium falciparum has repeatedly proven ability for mounting resistance to any anti-malarial drug regimen upon wider use, including current ones [2-7].”
BackgroundAshley, E. A., Phyo, A. P., Carrara, V. I., Tun, K. M., Nosten, F. H., Smithuis, F., & White, N. J. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz052 · Cited by 29
“The reduction in malaria incidence was earliest at the ThailandMyanmar border [10].”
BackgroundSelf-citationHashmi, A. H., Solomon, N., Lee, S. J., Min, A. M., Gilder, M. E., Wiladphaingern, J., Tun, N. W., Plugge, E., Wickramasinghe, K., Angkurawaranon, C., et al. (2019) · British Journal of Nutrition · doi:10.1017/s0007114519000758 · Cited by 28
“SMRU estimates that its clinics serve a catchment of approximately 200 000 migrants that has remained relatively stable since the late 1990s (34) .”
Self-citationYa-umphan, P., Cerqueira, D., Cottrell, G., Parker, D. M., Fowkes, F. J. I., Nosten, F. H., & Corbel, V. (2018) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.18-0081 · Cited by 29
“adult males along the TMB due to different behavior, movement, and occupation.(2) Other risk factors associated with sero-reactivity to P.”
BackgroundSelf-citationMalaria Elimination in the Greater Mekong Subregion: Challenges and Prospects
Cui, L., Cao, Y., Kaewkungwal, J., Khamsiriwatchara, A., Lawpoolsri, S., Soe, T. N., Kyaw, M. P., & Sattabongkot, J. (2018) · InTech eBooks · doi:10.5772/intechopen.76337 · Cited by 30
Harupa, A., Heras, L. D. L., Colmenarejo, G., Lyons-Abbott, S., Reers, A. R., Caballero, I., Chung, C., Charter, D., Myler, P. J., Fernández-Menéndez, R. M., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01343 · Cited by 28
Kunpeuk, W., Teekasap, P., Kosiyaporn, H., Julchoo, S., Phaiyarom, M., Sinam, P., Pudpong, N., & Suphanchaimat, R. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17145113 · Cited by 27
Win, A. Y. N., Maung, T. M., Wai, K. T., Oo, T., Thi, A., Tipmontree, R., Soonthornworasiri, N., Kengganpanich, M., & Kaewkungwal, J. (2017) · Malaria Journal · doi:10.1186/s12936-017-2113-4 · Cited by 27
K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
Win, A. A., Imwong, M., Kyaw, M. P., Woodrow, C. J., Chotivanich, K., Hanboonkunupakarn, B., & Pukrittayakamee, S. (2016) · Malaria Journal · doi:10.1186/s12936-016-1147-3 · Cited by 26
“Reduced in vivo responses to artemisinins have been confirmed in the southern extremity of Myanmar [10] and at the Myanmar-Thai [5, 6, 11] and Myanmar-China borders [12].”
BackgroundInfluentialRedefining priorities towards graded travel-related infectious disease research
Torresi, J., & Steffen, R. J. (2017) · Journal of Travel Medicine · doi:10.1093/jtm/tax064 · Cited by 27
Hashmi, A., Paw, M. K., Nosten, S., Darakamon, M. C., Gilder, M. E., Charunwatthana, P., Carrara, V. I., Wickramasinghe, K. K., Angkurawaranon, C., Plugge, E., et al. (2018) · Global Health Action · doi:10.1080/16549716.2018.1473104 · Cited by 30
“residing on both sides of the border frequently move to and from Myanmar but the total population, estimated at 200,000, is relatively stable [19,36,37].”
BackgroundSelf-citationHailemeskel, E., Menberu, T., Shumie, G., Behaksra, S., Chali, W., Keffale, M., Belachew, M., Shitaye, G., Mohammed, H., Abebe, D., et al. (2019) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2019.09.002 · Cited by 21
Oseni, Z., Than, H. H., Kolakowska, E., Chalmers, L., Hanboonkunupakarn, B., & McGready, R. (2017) · BMC Medical Education · doi:10.1186/s12909-017-0975-3 · Cited by 24
Self-citationKhirikoekkong, N., Jatupornpimol, N., Nosten, S., Asarath, S.-A., Hanboonkunupakarn, B., McGready, R. M., Nosten, F. H., van der Roest, J. G., Parker, M. J., Kelley, M. C., et al. (2020) · International Health · doi:10.1093/inthealth/ihaa052 · Cited by 27
Self-citationKhirikoekkong, N., Asarath, S.-A., Nosten, S., Hanboonkunupakarn, B., Jatupornpimol, N., van der Roest, J. G., Parker, M. J., Nosten, F. H., McGready, R. M., Cheah, P. Y., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001875 · Cited by 28
Self-citationMalaria: a molecular marker of artemisinin resistance
White, N. J. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60656-5 · Cited by 24
Self-citationPoor response to artesunate treatment in two patients with severe malaria on the Thai–Myanmar border
Phyo, A. P., Win, K., Thu, A. M., Swe, L. L., Htike, H., Beau, C., Sriprawat, K., Winterberg, M., Proux, S., Imwong, M., et al. (2018) · Malaria Journal · doi:10.1186/s12936-018-2182-z · Cited by 26
“There were only four cases of severe malaria hospitalized in Shoklo Malaria Research Unit between 2015 to date compared to 38 cases in 2011 [5].”
Self-citationHan, K. T., Lin, K., Myint, M. K., Thi, A., Aye, K. H., Han, Z. Y., Moe, M., Bustos, M. D., Rahman, M. M., Ringwald, P., et al. (2019) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.19-0692 · Cited by 23
“have reported an alarming decrease in efficacy of AM along the Thailand–Myanmar border, with 42-day cure rates as low as 42%.(9) The efficacy of AL remains high in Myanmar,(11)”
BackgroundHodoameda, P., Duah-Quashie, N. O., & Quashie, N. B. (2022) · Journal of Tropical Medicine · doi:10.1155/2022/3492696 · Cited by 26
“Reports of treatment failures with dihydroartemisinin-piperaquine (DHAP) in Cambodia [12–14] and artesunate-mefloquine (ASMQ) on the *aiMyanmar border [15] support this assertion.”
BackgroundThan, W. P., Oo, T., Wai, K. T., Thi, A., Owiti, P., Kumar, B., Shewade, H. D., & Zachariah, R. (2017) · Infectious Diseases of Poverty · doi:10.1186/s40249-017-0353-8 · Cited by 25
From control to elimination: a spatial-temporal analysis of malaria along the China-Myanmar border
Huang, F. J., Zhang, L., Xue, J.-B., Zhou, H., Thi, A., Zhang, J., Zhou, S., Xia, Z., & Zhou, X. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00777-1 · Cited by 23
The effect and control of malaria in pregnancy and lactating women in the Asia-Pacific region
Unger, H. W., Acharya, S., Arnold, L., Wu, C., van Eijk, A. M., Gore‐Langton, G. R., ter Kuile, F. O., Lufele, E., Chico, R. M., Price, R. N., et al. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00415-1 · Cited by 25
Metadata
- Authors
- Carrara, V. I., Lwin, K. M., Phyo, A. P., Ashley, E., Wiladphaingern, J., Sriprawat, K., Rijken, M., Boel, M., McGready, R., Proux, S., Chu, C., Singhasivanon, P., White, N., & Nosten, F.
- Affiliations
- University of Oxford (GB)
- Shoklo Malaria Research Unit (TH)
- University Medical Center Utrecht (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Mahidol University (TH)
- Corresponding author
- Nosten, François
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-03-05
- Volume
- 10
- Issue
- 3
- Pages
- e1001398
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC3589269
- OpenAlex
- W2027634352
- Cited by
- 185
- References
- 29
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 8 · 2023: 13 · 2022: 6 · 2021: 5 · 2020: 7 · 2019: 18 · 2018: 10 · 2017: 24 · 2016: 27 · 2015: 28 · 2014: 18 · 2013: 8
- FWCI
- 27.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Funders
- Wellcome Trust (089275)
- Mahidol University
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
- Keywords
- malaria, Plasmodium falciparum, artemisinin resistance, artesunate, antimalarial drug efficacy, malaria incidence, malaria prevalence, pregnant women, children under five, Plasmodium vivax, case fatality rate, cross-border healthcare, Thai-Myanmar border, Shoklo Malaria Research Unit
- MeSH terms
- Artesunate, Antimalarials, Myanmar, Climate, Community Health Workers, Cross-Sectional Studies, Drug Resistance, Female, Geography, Hospitalization, Humans, Malaria, Plasmodium falciparum, Plasmodium vivax, Pregnancy, Rain, Temperature, Thailand, Transients and Migrants, Reproducibility of Results, Pregnancy Complications, Parasitic, Mefloquine, Prevalence, Artemisinins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.